Ovarian cancer (OC), the most lethal gynecological malignancy, is the fifth leading cause of cancer-related death in women.

Co-Located Cell Types Help Drive Aggressive Brain Tumors Feb. 7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth ...

The wife of a Cuban man battling a brain tumor has turned to social media, pleading for financial assistance to fund his medical treatment in Guyana, ...

As Jeff Yoshimi, PhD, wrote his book about how video games could improve scientific literacy on cancer and generate ideas ...

Breast cancer remains the most frequently diagnosed malignancy in women in the United States, with nearly 317,000 new cases expected in 2025.  In addi | Cancer ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

Dosing has started in a clinical evaluating peluntamig, which targets DLL3 and CD47, combined with chemotherapy in patients ...

American Urological Association Releases Microhematuria Guideline Amendment This guideline provides a clinical framework for ...

The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

“When species needed to grow larger, they also evolved remarkable defenses against cancer,” said Dr. Joanna Baker, a ...